{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:14:25Z","timestamp":1792134865891,"version":"4.4.0"},"reference-count":29,"publisher":"Society of Nuclear Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,6,25]]},"published-print":{"date-parts":[[2026,1]]},"DOI":"10.2967\/jnumed.125.269633","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T17:20:12Z","timestamp":1754587212000},"page":"23-30","source":"Crossref","is-referenced-by-count":13,"title":["[\n                    <sup>177<\/sup>\n                    Lu]Lu-DOTATATE for Recurrent Meningioma (LUMEN-1, EORTC-2334-BTG): Study Protocol for a Randomized Phase II Trial"],"prefix":"10.2967","volume":"67","author":[{"given":"Nathalie L.","family":"Albert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeline","family":"Tabouret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Le Rhun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Sahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Furtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg-Christian","family":"Tonn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Alfano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Pais","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Govaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Gorlia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osvaldo","family":"Mirante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Minniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Preusser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"2026010206300897000_67.1.23.1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noae145"},{"key":"2026010206300897000_67.1.23.2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106"},{"key":"2026010206300897000_67.1.23.3","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab150"},{"key":"2026010206300897000_67.1.23.4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/s13063-015-1040-3","article-title":"The ROAM\/EORTC-1308 trial: radiation versus observation following surgical resection of atypical meningioma\u2014study protocol for a randomised controlled trial","volume":"16","author":"Jenkinson","year":"2015","journal-title":"Trials."},{"key":"2026010206300897000_67.1.23.5","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/neuonc\/noae082","article-title":"Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients","volume":"26","author":"Wang","year":"2024","journal-title":"Neuro Oncol."},{"key":"2026010206300897000_67.1.23.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607427"},{"key":"2026010206300897000_67.1.23.7","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00572-6"},{"key":"2026010206300897000_67.1.23.8","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3390\/cancers15030980","article-title":"Hormone receptor expression in meningiomas: a systematic review","volume":"15","author":"Agopiantz","year":"2023","journal-title":"Cancers (Basel)."},{"key":"2026010206300897000_67.1.23.9","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1093\/neuonc\/noae069","article-title":"Radioligand therapies in meningioma: evidence and future directions","volume":"26","author":"Mair","year":"2024","journal-title":"Neuro Oncol."},{"key":"2026010206300897000_67.1.23.10","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00259-022-06044-9","article-title":"Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma","volume":"50","author":"Minczeles","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026010206300897000_67.1.23.11","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/now060"},{"key":"2026010206300897000_67.1.23.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.249607"},{"key":"2026010206300897000_67.1.23.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266956"},{"key":"2026010206300897000_67.1.23.14","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1158\/1078-0432.CCR-23-2533","article-title":"Evaluation of the SSTR2-targeted radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as imaging biomarker in patients with intracranial meningioma","volume":"30","author":"Kurz","year":"2024","journal-title":"Clin Cancer Res."},{"key":"2026010206300897000_67.1.23.15","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noae253"},{"key":"2026010206300897000_67.1.23.16","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/annonc\/mdy263","article-title":"A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of Molecular Targets (ESCAT)","volume":"29","author":"Mateo","year":"2018","journal-title":"Ann Oncol."},{"key":"2026010206300897000_67.1.23.17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7586"},{"key":"2026010206300897000_67.1.23.18","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noy137"},{"key":"2026010206300897000_67.1.23.19","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.5.365"},{"key":"2026010206300897000_67.1.23.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.01.012"},{"key":"2026010206300897000_67.1.23.21","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nox029"},{"key":"2026010206300897000_67.1.23.22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8347"},{"key":"2026010206300897000_67.1.23.23","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr587"},{"key":"2026010206300897000_67.1.23.24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1200\/JCO.2001.19.1.265","article-title":"Clinical trial designs for cytostatic agents: are new approaches needed?","volume":"19","author":"Korn","year":"2001","journal-title":"J Clin Oncol."},{"key":"2026010206300897000_67.1.23.25","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/not330"},{"key":"2026010206300897000_67.1.23.26","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1007\/s00259-024-06783-x","article-title":"Joint EANM\/EANO\/RANO\/SNMMI practice guideline\/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0","volume":"51","author":"Albert","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026010206300897000_67.1.23.27","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s13063-024-08213-7","article-title":"Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study","volume":"25","author":"Preusser","year":"2024","journal-title":"Trials."},{"key":"2026010206300897000_67.1.23.28","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab243"},{"key":"2026010206300897000_67.1.23.29","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.149120"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.269633","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T14:30:18Z","timestamp":1767364218000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.269633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,2]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.2967\/jnumed.125.269633"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.269633","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]}}}